HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Manuel Guzmán Selected Research

Endoplasmic Reticulum Chaperone BiP

11/2021BiP Heterozigosity Aggravates Pathological Deterioration in Experimental Amyotrophic Lateral Sclerosis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Manuel Guzmán Research Topics

Disease

39Neoplasms (Cancer)
04/2023 - 01/2003
20Glioma (Gliomas)
01/2023 - 04/2002
9Breast Neoplasms (Breast Cancer)
01/2023 - 07/2006
8Huntington Disease (Huntington's Disease)
01/2020 - 11/2009
7Neurodegenerative Diseases (Neurodegenerative Disease)
01/2023 - 04/2007
6Neoplasm Metastasis (Metastasis)
04/2023 - 04/2006
5Glioblastoma (Glioblastoma Multiforme)
03/2008 - 08/2004
3Melanoma (Melanoma, Malignant)
04/2023 - 12/2006
3Neuroinflammatory Diseases
01/2019 - 01/2008
3Abdominal Obesity
08/2015 - 01/2008
3Obesity
10/2011 - 06/2003
2Parkinson Disease (Parkinson's Disease)
11/2021 - 08/2011
2Ataxia (Dyssynergia)
12/2020 - 01/2019
2Nervous System Diseases (Neurological Disorders)
01/2020 - 08/2007
2Cognitive Dysfunction
01/2020 - 02/2005
2Triple Negative Breast Neoplasms
11/2018 - 01/2016
2Malformations of Cortical Development
01/2018 - 11/2017
2Stroke (Strokes)
01/2017 - 04/2007
2Cardiovascular Diseases (Cardiovascular Disease)
07/2014 - 08/2013
2Rheumatoid Arthritis
03/2014 - 06/2005
2Infections
03/2014 - 12/2013
2Metabolic Syndrome (Dysmetabolic Syndrome X)
09/2012 - 01/2008
2Disease Progression
08/2011 - 01/2011
2Multiple Sclerosis
05/2008 - 04/2007
2Brain Injuries (Brain Injury)
08/2007 - 04/2007
2Chronic Renal Insufficiency
10/2003 - 02/2003
2Atrial Fibrillation
10/2003 - 02/2003
1Rare Diseases (Rare Disease)
03/2024
1Memory Disorders (Memory Loss)
03/2024
1Seizures (Absence Seizure)
12/2023
1Brain Neoplasms (Brain Tumor)
04/2023
1Critical Illness (Critically Ill)
07/2022
1Oropharyngeal Neoplasms
11/2021
1Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease)
11/2021
1Demyelinating Diseases (Demyelinating Disease)
01/2021
1Type C Niemann-Pick Disease (Niemann Pick Disease, Type C)
11/2020
1Niemann-Pick Diseases (Niemann Pick Disease)
11/2020
1Gliosis
01/2019
1Dry Eye Syndromes (Dry Eye Syndrome)
04/2018

Drug/Important Bio-Agent (IBA)

44CannabinoidsIBA
03/2024 - 04/2002
18Dronabinol (THC)FDA LinkGeneric
12/2020 - 04/2002
15Cannabinoid Receptors (Cannabinoid Receptor)IBA
01/2023 - 01/2003
11EndocannabinoidsIBA
01/2023 - 03/2007
11CeramidesIBA
11/2016 - 04/2002
7Proteins (Proteins, Gene)FDA Link
12/2023 - 04/2006
51,1-dimethylbutyl-1-deoxy-Delta(9)-THCIBA
01/2017 - 01/2003
5Cannabinoid Receptor AgonistsIBA
01/2011 - 12/2002
4CB1 Cannabinoid Receptor (CB1 Receptor)IBA
03/2024 - 01/2016
4LipidsIBA
01/2023 - 06/2003
4HDL CholesterolIBA
08/2015 - 01/2008
3Biomarkers (Surrogate Marker)IBA
01/2019 - 06/2015
3Temozolomide (Temodar)FDA LinkGeneric
11/2018 - 01/2011
3CannabidiolIBA
11/2018 - 01/2011
3LigandsIBA
01/2016 - 10/2009
3Triglycerides (Triacylglycerol)IBA
08/2015 - 07/2004
3Glucose (Dextrose)FDA LinkGeneric
08/2015 - 01/2008
3CB2 Cannabinoid ReceptorIBA
06/2015 - 07/2006
3Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA
10/2009 - 08/2002
3Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
08/2004 - 01/2003
2fatty-acid amide hydrolase (fatty acid amide hydrolase)IBA
01/2023 - 11/2020
2nabiximols (Sativex)IBA
11/2018 - 07/2016
2TOR Serine-Threonine KinasesIBA
01/2018 - 07/2015
2Mechanistic Target of Rapamycin Complex 1IBA
01/2018 - 10/2013
2G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA
01/2016 - 08/2014
2LDL CholesterolIBA
08/2015 - 10/2011
2Insulin (Novolin)FDA Link
07/2014 - 08/2013
2CholesterolIBA
03/2014 - 10/2011
2C-Reactive ProteinIBA
09/2012 - 10/2011
2Fibrinogen (Factor I)FDA Link
09/2012 - 10/2011
2Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
09/2011 - 01/2003
2Matrix Metalloproteinase 2 (Gelatinase A)IBA
03/2008 - 03/2003
2fumonisin B1IBA
03/2008 - 01/2008
2Angiopoietin-2IBA
03/2003 - 01/2003
1Therapeutic UsesIBA
12/2023
1N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA
04/2023
1Glutamic Acid (Glutamate)FDA Link
04/2023
1Glutamate Receptors (Glutamate Receptor)IBA
04/2023
1alpha- Amino- 3- hydroxy- 5- methyl- 4- isoxazolepropionic Acid (AMPA)IBA
04/2023
1Neurotransmitter Agents (Neurotransmitter)IBA
04/2023
1Phenobarbital (Luminal)FDA Link
01/2023
1EnzymesIBA
01/2023
1p38 Mitogen-Activated Protein KinasesIBA
11/2021
1Antineoplastic Agents (Antineoplastics)IBA
11/2021
1Endoplasmic Reticulum Chaperone BiPIBA
11/2021
1glyceryl 2-arachidonate (2-arachidonoylglycerol)IBA
01/2021
1DisaccharidesIBA
12/2020
1temsirolimusFDA Link
12/2020
1TrehaloseIBA
12/2020
1SphingolipidsIBA
11/2020
1SphingomyelinsIBA
11/2020
1Dopamine D1 Receptors (Dopamine D1 Receptor)IBA
01/2020
1Histamine H3 Receptors (Histamine H3 Receptor)IBA
01/2020
1human ERBB2 proteinIBA
01/2019
1JZL 184IBA
01/2019
1antiglomerular basement membrane antibodyIBA
11/2018
1Lubricant Eye Drops (Artificial Tears)IBA
04/2018
1Liposomes (Liposome)IBA
04/2018

Therapy/Procedure

17Therapeutics
03/2024 - 01/2003
2Oral Administration
01/2019 - 11/2018
1Length of Stay
07/2022